View CytoMed Therapeutics Limited GDTC stock quote prices, financial information, real-time forecasts, and company news from CNN.

CytoMed (NASDAQ: GDTC) stock is down 33% over the last 24 hours. GDTC stock fell in a mixture of real trading time, the aftermarket and now this morning. The reason for the decline is simply that it ...

CytoMed (NASDAQ: GDTC) stock is up 100%. The rise in GDTC stock seems to be coming from the award of a patent. This is a very silly idea, quite ridiculous. Of course, it's just great for those who ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Malaysian biotech CytoMed Therapeutics (GDTC) has filed for a proposed $15M initial public offering. CytoMed didn't state in its filing the number and price of the shares it intends to offer but did ...

Looking for more tickers? Browse the full market events calendar. The most recent corporate event for CytoMed Therapeutics (GDTC) was Investor Meeting (Summit) on October 28, 2024 at 8:00 AM.

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released ...